GlassScriptPhysician profile
Jennifer L Sobol
NPI 1558326926
$41,992.70
in general payments reported to CMS, 2019-2025
37 companies · $9,309 in 2025
The $9,309 reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $4,801 · 2021: $15K · 2022: $5,489 · 2023: $4,293 · 2024: $1,984 · 2025: $9,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,207 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $2,976 · Honoraria: $367 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,206.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $2,976.38 |
| Honoraria | $367.33 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19,720.54 | 2019-2022 | |
| Abbvie INC. | $11,539.56 | 2022-2025 | Botox |
| Medtronic, INC. | $5,864.65 | 2021-2025 | Interstim |
| Axonics, INC. | $1,458.84 | 2022-2024 | Bulkamid, Axonics |
| Medtronic USA, INC. | $568.07 | 2019-2020 | |
| Coloplast Corp | $557.37 | 2019-2024 | Speedicath, Saffron, Porges Coloplast |
| Astellas Pharma US INC | $264.90 | 2019-2025 | Xtandi, Myrbetriq |
| Merck Sharp & Dohme LLC | $217.55 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Sumitomo Pharma America, INC. | $214.15 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $194.47 | 2023-2025 | Axonics, General - Female Sui, Ams 700 |
| Myriad Genetic Laboratories, INC. | $127.83 | 2023 | Prolaris |
| Pfizer INC. | $124.74 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.78 | 2023-2025 | |
| Janssen Biotech, INC. | $97.74 | 2024-2025 | Erleada, Carvykti, Rybrevant |
| Progenics Pharmaceuticals, INC. | $94.34 | 2022-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $85.94 | 2022-2025 | Itind System |
| Urogen Pharma, INC. | $82.80 | 2024-2025 | |
| Forte Bio-Pharma LLC | $81.05 | 2025 | Prolate, Nalocet, Tanlor |
| Avation Medical, INC. | $75.39 | 2024-2025 | Vivally System, Vivally |
| Astrazeneca Pharmaceuticals LP | $71.96 | 2025 | Lynparza, Imfinzi |
| C. R. Bard, INC. & Subsidiaries | $59.79 | 2023-2025 | Bard Urinary Drainage Bag |
| Dendreon Pharmaceuticals LLC | $46.50 | 2024-2025 | Provenge |
| 180 Medical, INC. | $45.76 | 2022-2023 | |
| Angiodynamics, INC. | $39.23 | 2024-2025 | Nanoknife |
| Endo Pharmaceuticals INC. | $38.09 | 2022-2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $35.36 | 2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $26.20 | 2024 | |
| Photocure INC | $23.98 | 2023 | Cysview |
| Calyxo, INC. | $21.91 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $19.29 | 2024 | |
| Endo USA, INC. | $18.85 | 2024 | Xiaflex |
| Teleflex LLC | $18.02 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.39 | 2022 | |
| Tolmar, INC. | $14.57 | 2024 | |
| Therapeuticsmd, INC. | $11.09 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Sobol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.